Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial assesses the effect of esketamine on abdominal pain in patients with hepatocellular carcinoma undergoing transarter…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 3]
Phase 3 clinical trial evaluating chemoembolization with or without sorafenib for unresectable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT [Phase 3]
Phase 3 trial comparing SBRT+TACE+Sorafenib versus Sorafenib alone in unresectable hepatocellular carcinoma with portal vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC [Phase 2]
Phase 2 trial update investigating TACE combined with Tilelizumab and Sorafenib for BCLC Stage C hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Hepatocellular Carcinoma Surveillance in Cirrhotics [NA]
Clinical trial update on hepatocellular carcinoma surveillance in patients with cirrhosis; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Impact of Y90 Radiation Segmentectomy on HCC [NA]
Clinical trial update on Y-90 radiation segmentectomy for hepatocellular carcinoma has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH) [Phase 3]
A Phase 3 trial evaluating SBRT plus lenvatinib and TACE for advanced hepatocellular carcinoma is in the NOT_YET_RECRUITING stage.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC [Phase 2]
Phase 2 trial update of HAIC combined with sintilimab and a bevacizumab biosimilar in unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects [Phase 3]
Phase III study comparing Icaritin to Sorafenib in PD-L1 positive advanced hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC [Phase 1, Phase 2]
A combined TACE and Lenvatinib trial in hepatocellular carcinoma with microvascular invasion aims to prevent postoperative recurrence; curre…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/II study of Fisogatinib (BLU-554) in hepatocellular carcinoma has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Neoadjuvant Anti-PD1 in HCC [Phase 2]
Phase 2 neoadjuvant anti-PD1 trial in hepatocellular carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]
Phase 4 trial investigating atezolizumab and bevacizumab before liver transplantation in hepatocellular carcinoma patients beyond Milan crit…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Simo Decoction and Gum Chewing for Bowel Activity [Phase 3]
Phase 3 clinical trial update investigating Simo Decoction and gum chewing for bowel activity in hepatocellular carcinoma patients has compl…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Adjuvant Radiotherapy Comparing TACE for Curative HCC [Phase 3]
A Phase 3 clinical trial comparing adjuvant radiotherapy versus transarterial chemoembolization (TACE) for curative treatment in hepatocellu…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial assesses durvalumab plus lenvatinib as first-line therapy for unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence [Phase 2]
Phase 2 trial evaluating anlotinib in combination with TACE for hepatocellular carcinoma patients at high risk of post-surgical recurrence.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating [68Ga]DOTATATE-PET/MRI in hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation [Phase 2]
Phase 2 trial update on intraprocedural assessment of ablation margins using CT co-registration in percutaneous ablation for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated the safety of Talimogene laherparepvec injected into tumors alone and in combination with pembrolizumab…
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update on Lipiodol-TACE with idarubicin for hepatocellular carcinoma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: TACE Combined With Penpulimab and Anlotinib for Advanced HCC [Phase 2, Phase 3]
Phase 2/3 trial evaluating TACE with penpulimab and anlotinib for advanced hepatocellular carcinoma is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis [Phase 2]
Phase 2 trial comparing octanoate breath test to MRI for diagnosis of hepatocellular carcinoma (HCC) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial update evaluating prophylactic antibiotic use during transarterial chemoembolization for hepatocellular carcinoma. Cu…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) [Phase 2]
Phase 2 clinical trial evaluating AK104 in combination with TACE for resectable hepatocellular carcinoma.